L. Achtem
YOU?
Author Swipe
View article: Early mobilization after transcatheter aortic valve implantation: observational cohort study
Early mobilization after transcatheter aortic valve implantation: observational cohort study Open
Aims Early mobilization is associated with improved outcomes in hospitalized older patients. We sought to determine the effect of a nurse-led protocol on mobilization 4 h after transfemoral transcatheter aortic valve implantation (TAVI) ac…
View article: The road to a transcatheter edge-to-edge repair: patient experiences leading up to the procedure and in the early recovery period
The road to a transcatheter edge-to-edge repair: patient experiences leading up to the procedure and in the early recovery period Open
Aims Mitral valve transcatheter edge-to-edge repair (TEER) is a minimally invasive treatment option for patients with severe symptomatic mitral regurgitation who are at increased risk for cardiac surgery and are receiving optimal medical t…
View article: Validation of the virtual measurement of the Essential Frailty Toolset
Validation of the virtual measurement of the Essential Frailty Toolset Open
Funding Acknowledgements Type of funding sources: None. Background The Essential Frailty Toolset (EFT) is a valid measurement of frailty in people with heart valve disease. COVID-19 has prompted the transition to virtual health consultatio…
View article: Can you see frailty? An exploratory study of the use of a patient photograph in the transcatheter aortic valve implantation programme
Can you see frailty? An exploratory study of the use of a patient photograph in the transcatheter aortic valve implantation programme Open
Background Frailty is an important consideration in the assessment of transcatheter aortic valve implantation patients. The documentation of a patient photograph to augment the objective measurement of frailty has been adopted by some tran…
View article: Facilitating transcatheter aortic valve implantation in the era of COVID-19: Recommendations for programmes
Facilitating transcatheter aortic valve implantation in the era of COVID-19: Recommendations for programmes Open
The COVID-19 pandemic continues to significantly impact the treatment of people living with aortic stenosis, and access to transcatheter aortic valve implantation. Transcatheter aortic valve implantation (TAVI) programmes require unique co…
View article: Safety of Accelerated Recovery on a Cardiology Ward and Early Discharge Following Minimalist TAVR in the Catheterization Laboratory: The Vancouver Accelerated Recovery Clinical Pathway
Safety of Accelerated Recovery on a Cardiology Ward and Early Discharge Following Minimalist TAVR in the Catheterization Laboratory: The Vancouver Accelerated Recovery Clinical Pathway Open
BackgroundWe assessed the safety and efficacy of a clinical pathway with transfemoral transcatheter aortic valve replacement (TAVR) performed in the catheterization laboratory, accelerated recovery on a general cardiology ward and early di…
View article: Understanding experiences of undergoing transcatheter aortic valve implantation: one-year follow-up
Understanding experiences of undergoing transcatheter aortic valve implantation: one-year follow-up Open
Background: Transcatheter aortic valve implantation (TAVI) is the treatment of choice for frail, older adults with severe symptomatic aortic stenosis. Although research about long-term clinical outcomes is emerging, there is limited eviden…
View article: Vancouver Transcatheter Aortic Valve Replacement Clinical Pathway
Vancouver Transcatheter Aortic Valve Replacement Clinical Pathway Open
We describe the development, implementation, and evaluation of a standardized clinical pathway to facilitate safe discharge home at the earliest time after transfemoral transcatheter aortic valve replacement. Between May 2012 and October 2…
View article: Transition to palliative care when transcatheter aortic valve implantation is not an option
Transition to palliative care when transcatheter aortic valve implantation is not an option Open
The increased availability of transcatheter options for the management of valvular heart disease will increase the assessment of people with life-limiting conditions for whom treatment may not be an option. It is pivotal to bridge cardiac …